Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact).
|胰臟·膽管支架:一般外科市場分析及預測模式 Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact).|
|出版日期: 2020年10月30日||內容資訊: 英文||
Pancreatic and Biliary stent (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact). is built to visualize quantitative market trends within General Surgery therapeutic area.
Pancreatic and Biliary stents are the tubular devices made either of plastic or metal. They are often used in the treatment of obstructive jaundice from either benign or malignant causes and in the management of biliary leaks. These stents are also for preventing post- endoscopic retrograde cholangiopancreatography pancreatitis and to drain the gallbladder and pancreatic fluids. These stents are placed through two major procedures: Endoscopic Retrograde Cholangio-Pancreatography (ERCP) and Percutaneous transhepatic cholangiography (PTC).
The Pancreatic and biliary stents market is mainly driven by the diseases resulting in the obstruction in bile or pancreatic ducts. Increase in the number of ERCP and PTC procedures has fueled the market especially the procedures requiring stenting and recurrent stenting.
Disorders of the biliary duct effect a major portion of the world and it is increasing every year which is evidenced by increase in the number of ERCP procedures. Biliary obstruction from malignant causes is quite common, with as many 70% of the pancreatic cancer patients presenting with obstruction upon diagnosis. Every year more than 500,000 ERCP procedures including diagnostic as well as surgical, are carried out alone in the United States.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Pancreatic and Biliary stent and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Boston Scientific Corp, Cook Group Inc, Cardinal Health Inc, Medtronic plc, ConMed Corp, W. L. Gore & Associates Inc, Taewoong Medical Co Ltd, Olympus Corp, Becton Dickinson and Co, Micro-Tech (Nanjing) Co Ltd, ELLA-CS sro, Abbott Laboratories, Endo-Flex GmbH, Hobbs Medical Inc , Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -